My Companies
Notification
Account
Log Out
Back

Mangalam Drugs And Organics Explores Sale Of Vapi Unit-2 Contributing 32% Revenue


18 November 2026
Mangalam Drugs And Organics Ltd.

Board on 18 Nov 2026 approved exploring sale of leasehold land/building at Unit-2, Vapi and EGM for approval. No buyer or price fixed. Unit did Rs74.5Cr, 32% of FY26 revenue. First move to sell core plant capacity amid NPA tagging, enforcement action and going-concern warning. Selling one of two Vapi units signals survival restructuring, not routine trim. Buyer, price, timeline, use of proceeds undisclosed; needs shareholder nods. Losing one-third revenue base raises execution risk. Watch EGM date and lender outcome.


Recent Events

Real time WhatsApp alerts using AI.

Get features of

  • Instant Notifications
  • Competitive Advantage
  • Critical Alerts
Signup or Sign in

Company Information